All Stories

  1. Ex Vivo Expansion of CD34+ CD90+ CD49f+ Hematopoietic Stem and Progenitor Cells from Non-enriched Umbilical Cord Blood with Azole Compounds
  2. Mitochondrial superoxide reduction and cytokine secretion skewing by carbon nanotube scaffolds enhance ex vivo expansion of human cord blood hematopoietic progenitors
  3. Dual-functionalized poly(amidoamine) dendrimers with poly(ethylene glycol) conjugation and thiolation improved blood compatibility
  4. Synthesis and biological activity of fluorinated 7-benzylamino-2-phenyl-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-amines
  5. Dendrimers in Oral Drug Delivery Application: Current Explorations, Toxicity Issues and Strategies for Improvement
  6. Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia
  7. Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: Synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II
  8. Dual-Functionalized PAMAM Dendrimers with Improved P-Glycoprotein Inhibition and Tight Junction Modulating Effect
  9. Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors
  10. Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft
  11. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood
  12. A structure–activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities
  13. Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing
  14. Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis
  15. Intercellular cytosolic transfer correlates with mesenchymal stromal cell rescue of umbilical cord blood cell viability during ex vivo expansion
  16. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration
  17. In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia
  18. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer
  19. Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft
  20. Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model
  21. Increased ERK activation and cellular drug accumulation in the enhanced cytotoxicity of folate receptor-targeted liposomal carboplatin
  22. Multivalent rituximab lipid nanoparticles as improved lymphoma therapies: indirect mechanisms of action andin vivoactivity
  23. Functionalized carbon nanomaterials: exploring the interactions with Caco-2 cells for potential oral drug delivery
  24. Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells
  25. Role of reactive oxygen species in the synergistic cytotoxicity of safingol-based combination regimens with conventional chemotherapeutics
  26. The functional roles of poly(ethylene glycol)‐lipid and lysolipid in the drug retention and release from lysolipid‐containing thermosensitive liposomes in vitro and in vivo
  27. Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment
  28. ChemInform Abstract: Fused Heterocyclic Systems with s-Triazine Ring. Part 14. Synthesis and Heterocyclizations of 3,4-Dihydroquinazolin-2-yl Guanidine in the Search of New Anticancer Agents.
  29. Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities
  30. DEVELOPMENT AND CHARACTERIZATION OF A NANOCARRIER FOR QUERCETIN
  31. Synthesis and Heterocyclizations of 3,4-Dihydroquinazolin-2-yl Guanidine in the Search of New Anticancer Agents
  32. ChemInform Abstract: Fused Heterocyclic Systems with s-Triazine Ring. Part 10. Synthesis and Biological Activity of Fluorinated 7-Aryl-2-pyridyl-6,7-dihydro[1,2,4]triazolo[1,5-a] [1,3,5]triazin-5-amines.
  33. Synthesis and biological activity of fluorinated 7-aryl-2-pyridyl-6,7-dihydro[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-amines
  34. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes
  35. A Cationic Liposomal Vincristine Formulation with Improved Vincristine Retention, Extended Circulation Lifetime and Increased Anti-Tumor Activity
  36. Optimization and Therapeutic Activity of Liposome-Conjugated Monoclonal Antibodies Against the ErbB family of Receptor Tyrosine Kinases: First Step in the Development of Therapeutic Antibody/Liposomal Anticancer Drug Combinations
  37. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese
  38. Targeting of antibody conjugated, phosphatidylserine-containing liposomes to vascular cell adhesion molecule 1 for controlled thrombogenesis
  39. Application of purging biotinylated liposomes from plasma to elucidate influx and efflux processes associated with accumulation of liposomes in solid tumors
  40. Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems
  41. Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids
  42. Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol)